Inhibition of GLS suppresses proliferation and promotes apoptosis in prostate cancer
Open Access
- 25 June 2019
- journal article
- research article
- Published by Portland Press Ltd. in Bioscience Reports
- Vol. 39 (6)
Abstract
Altered glutamine metabolism is a hallmark of cancer growth, forming the theoretical basis for development of metabolic therapies as cancer treatments. Glutaminase (GLS), a crucial enzyme involved in the regulation of glutamine metabolism, has been reported to play crucial roles in cancer development. However, the precise function of GLS in prostate cancer (PCa) remains unclear. The purpose of the present study was to assess the GLS expression and its clinical significance in PCa. We found that GLS was significantly up-regulated in PCa tissues and cell lines. High expression of GLS was significantly associated with Gleason score (P=0.001) and Tumor stage (P=0.015). Functionally, we silenced GLS in PCa cell lines and revealed that GLS knockdown largely blunted the proliferation of DU145 and PC-3 cells. Mechanistically, we demonstrated that knockdown of GLS induced apoptosis and cell cycle arrest. Moreover, we observed that the expressions of Bax were increased while the levels of cyclinD1 and Bcl-2 were decreased after knockdown of GLS in PCa cells. Importantly, through Western blot analysis, we identified that GLS knockdown dramatically suppressed Wnt/β-catenin pathway. Taken together, GLS is a novel oncogene in PCa and may be a potential treatment target for PCa patients.Keywords
This publication has 28 references indexed in Scilit:
- Prostate cancerThe Lancet, 2016
- Targeted inhibition of tumor-specific glutaminase diminishes cell-autonomous tumorigenesisJournal of Clinical Investigation, 2015
- Elevated expression of glutaminase confers glucose utilization via glutaminolysis in prostate cancerBiochemical and Biophysical Research Communications, 2015
- RETRACTED: Synthetic lethality of combined glutaminase and Hsp90 inhibition in mTORC1-driven tumor cellsProceedings of the National Academy of Sciences, 2014
- Antitumor Activity of the Glutaminase Inhibitor CB-839 in Triple-Negative Breast CancerMolecular Cancer Therapeutics, 2014
- Targeting the PI3K/Akt/mTOR pathway in castration-resistant prostate cancerEndocrine-Related Cancer, 2013
- Reprogramming of proline and glutamine metabolism contributes to the proliferative and metabolic responses regulated by oncogenic transcription factor c-MYCProceedings of the National Academy of Sciences, 2012
- Mitochondrial localization and structure-based phosphate activation mechanism of Glutaminase C with implications for cancer metabolismProceedings of the National Academy of Sciences, 2012
- Inhibition of Glutaminase Preferentially Slows Growth of Glioma Cells with Mutant IDH1Cancer Research, 2010
- Targeting Mitochondrial Glutaminase Activity Inhibits Oncogenic TransformationCancer Cell, 2010